Trial Outcomes & Findings for Extubation With or Without Spontaneous Breathing Trial (NCT NCT01020773)
NCT ID: NCT01020773
Last Updated: 2009-11-26
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
67 participants
Primary outcome timeframe
13 months
Results posted on
2009-11-26
Participant Flow
Participant milestones
| Measure |
SBT Group
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
|
No-SBT Group
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
|
|---|---|---|
|
Overall Study
STARTED
|
35
|
32
|
|
Overall Study
COMPLETED
|
31
|
29
|
|
Overall Study
NOT COMPLETED
|
4
|
3
|
Reasons for withdrawal
| Measure |
SBT Group
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
|
No-SBT Group
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
4
|
3
|
Baseline Characteristics
Extubation With or Without Spontaneous Breathing Trial
Baseline characteristics by cohort
| Measure |
SBT Group
n=35 Participants
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
|
No-SBT Group
n=32 Participants
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
|
Total
n=67 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1.0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
38.0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
15 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
28.0 Participants
n=5 Participants
|
|
Age Continuous
|
58.9 years
STANDARD_DEVIATION 16.3 • n=5 Participants
|
56.7 years
STANDARD_DEVIATION 18.0 • n=7 Participants
|
57.9 years
STANDARD_DEVIATION 17.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
25.0 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
22 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
42.0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 13 monthsOutcome measures
| Measure |
SBT Group
n=31 Participants
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
|
No-SBT Group
n=29 Participants
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
|
|---|---|---|
|
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
Successful extubation
|
28 participants
|
29 participants
|
|
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
Reintubation
|
3 participants
|
3 participants
|
|
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
In hospital mortality
|
3 participants
|
4 participants
|
Adverse Events
SBT Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
No-SBT Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Department of Respiratory Medicine
Beijing Shijitan Hospital
Phone: 86-010-63926385
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place